Wednesday, November 7, 2007 - 10:20 AM
336f
The Use Of Pat In The Laboratory To Define And Optimize Api Manufacturing Processes
Mark A. LaPack
, Chemical Process R&D, Eli Lilly and Company, Lilly Research Labs South, Indianapolis, IN 46285
Text Not Available.
See more of
#336 - Advances in Api Process Development (TI021)
See more of
Topical I: Pharmaceutical Engineering for the 21Century
See more of
The 2007 Annual Meeting